Does Rallies show Form 4 insider transactions for ENSC?

Yes. Rallies tracks ENSC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is ENSC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ENSC. It does not provide personalized investment advice.

ENSC (Ensysce Biosciences, Inc. Common Stock) Stock Analysis - Insider Trades

Ensysce Biosciences, Inc. Common Stock (ENSC) is a publicly traded Healthcare sector company. As of May 21, 2026, ENSC trades at $0.31 with a market cap of $2.94M and a P/E ratio of -0.08. ENSC moved +3.27% today. Year to date, ENSC is -70.19%; over the trailing twelve months it is -87.19%. Its 52-week range spans $0.23 to $14.67. Rallies surfaces ENSC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ENSC stock inside the company?

Recent ENSC insider activity includes GOWER BOB G bought 90.29K, GOWER BOB G bought 270.00K, GOWER BOB G bought 109.30K, GOWER BOB G bought 357.14K, and Kirkpatrick Lynn bought 27.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

ENSC Key Metrics

Key financial metrics for ENSC
Metric	Value
Price	$0.31
Market Cap	$2.94M
P/E Ratio	-0.08
EPS	$-3.98
Dividend Yield	0.00%
52-Week High	$14.67
52-Week Low	$0.23
Volume	52.66K
Avg Volume	0
Revenue (TTM)	$5.07M
Net Income	$-10.18M
Gross Margin	0.00%

Recent ENSC Insider Trades

GOWER BOB G bought 90.29K (~$44.09K) on Mar 2, 2023.
GOWER BOB G bought 270.00K (~$128.98K) on Mar 1, 2023.
GOWER BOB G bought 109.30K (~$53.37K) on Feb 28, 2023.
GOWER BOB G bought 357.14K (~$500.00K) on Dec 9, 2022.
Kirkpatrick Lynn bought 27.00K (~$14.22K) on May 26, 2022.

Latest ENSC News

Ensysce Achieves 50% PF614-301 Enrollment, Secures IRB Approval and Expands Patents — May 15, 2026
Ensysce Biosciences Extends MPAR Overdose Protection Patent in Taiwan to 2042 — May 12, 2026
Ensysce Biosciences Closes $2M Convertible Financing with $0.55 Conversion Price — Apr 7, 2026
Ensysce Biosciences Reaches PF614 Phase 3 Enrollment, Breakthrough Designation; Cash at $4.3M — Mar 30, 2026
Ensysce Biosciences Launches Live Q&A Highlighting PF614 Phase 3 Timeline and Commercial Potential — Mar 4, 2026

ENSC Analyst Consensus

ENSC analyst coverage data. Average price target: $0.00.

Common questions about ENSC

Who is trading ENSC stock inside the company?: Recent ENSC insider activity includes GOWER BOB G bought 90.29K, GOWER BOB G bought 270.00K, GOWER BOB G bought 109.30K, GOWER BOB G bought 357.14K, and Kirkpatrick Lynn bought 27.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ENSC?: Yes. Rallies tracks ENSC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ENSC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ENSC. It does not provide personalized investment advice.